Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Video: Interview With Christopher Viehbacher Of Gurnet Point Capital

This article was originally published in The Pink Sheet Daily

Executive Summary

Since his departure from Sanofi, Viehbacher has taken on a significant role in venture capital; at the recent BioPharm America conference, he spoke about his company's business model and goals, as well as the trend of pharma execs moving to smaller companies.

Advertisement

Related Content

Video: Interview With Sarah Frew Of Penn's Center For Innovation
Video: Interview With Ovid Therapeutics' Jeremy Levin
Video: Interview With Baiju Shah Of BioMotiv
Video: Biomarker And Precision Medicine Advances Highlighted At BioPharm America Panel

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS078952

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel